Expression of Shelterin Component <i>POT1</i> Is Associated with Decreased Telomere Length and Immunity Condition in Humans with Severe Aplastic Anemia

<table>POT1 mRNA expression in normal BMMNCs is reduced in the presence of SAA serum or IFN-<i>γ</i>.</table>

Journal of Immunology Research

fig6

Figure 6

Figure 6: Expression of Shelterin Component <i>POT1</i> Is Associated with Decreased Telomere Length and Immunity Condition in Humans with Severe Aplastic Anemia 

Figure 6 | Expression of Shelterin Component POT1 Is Associated with Decreased Telomere Length and Immunity Condition in Humans with Severe Aplastic Anemia 